Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

Physician-researcher to lead pediatric Dream Team to create new treatments for childhood cancers

Physician-researcher to lead pediatric Dream Team to create new treatments for childhood cancers

Penn Medicine scientist, trial participant detail experiences on leading edge of gene therapy

Penn Medicine scientist, trial participant detail experiences on leading edge of gene therapy

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Emergent BioSolutions provides update on TRU-016 Phase 1b study

Emergent BioSolutions provides update on TRU-016 Phase 1b study

UC San Francisco researchers outline cell-based therapeutics as a "third pillar” of medicine

UC San Francisco researchers outline cell-based therapeutics as a "third pillar” of medicine

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

Media outlets examine reaction to India's Supreme Court ruling on Novartis patent case

Media outlets examine reaction to India's Supreme Court ruling on Novartis patent case

Doctors give new hope for leukemia patients

Doctors give new hope for leukemia patients

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Researchers discover new type of deadly intestinal lymphoma common in Asia

Researchers discover new type of deadly intestinal lymphoma common in Asia

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

KineMed renews research collaboration with Pfizer for advancement of novel diabetes pathways

KineMed renews research collaboration with Pfizer for advancement of novel diabetes pathways

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen announces acquisition of Cardioxane from Novartis

Researchers identify monoclonal antibody that directly kills lymphocytic leukemia cells

Researchers identify monoclonal antibody that directly kills lymphocytic leukemia cells

Novel cell therapy effective in treating aggressive form of childhood leukemia

Novel cell therapy effective in treating aggressive form of childhood leukemia

Scientists develop new chemo drug that fights cancer without impacting fertility

Scientists develop new chemo drug that fights cancer without impacting fertility

Researchers expand hematopoietic stem cells for bone marrow transplantation

Researchers expand hematopoietic stem cells for bone marrow transplantation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.